[Changes in glycosaminoglycans and glycoproteins during development of proliferative inflamed tissue and effect of anti-inflammatory drugs on the metabolism of these hexosamine-containing substances (author's transl)].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001623:Betamethasone / Q000494:pharmacology; D002351:Carrageenan; D002807:Chondroitin / Q000494:pharmacology; D006023:Glycoproteins / Q000378:metabolism*; D006025:Glycosaminoglycans / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006099:Granuloma / Q000139:chemically induced / Q000378:metabolism*; D008297:Male; D010396:Penicillamine / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D051381:Rats
D000893:Anti-Inflammatory Agents; D006023:Glycoproteins; D006025:Glycosaminoglycans; D002351:Carrageenan; D002807:Chondroitin; D001623:Betamethasone; D010653:Phenylbutazone; D010396:Penicillamine